Invasion and Metastasis
Cancer invasion and metastasis occur in a complex three dimensional environment, with reciprocal feedback from the surrounding host tissue and stroma governing cancer cell behaviour. Understanding this behaviour in an intact host setting allows us to examine, in a more physiological context, the aberrant regulation of critical events that lead to dissemination and spread of the primary tumour. Intravital (in vivo) imaging is providing new insights on how cells behave in their native microenvironment thereby improving our understanding of disease progression.
In our laboratory we use novel state-of-the-art intravital imaging approaches and new fluorescent mouse models to uncouple the metastatic process into key stages in order to pinpoint critical events that drive tumour invasion and metastasis. Our approach permits real-time imaging ranging from whole body tumour progression to single-cell invasion events, and helps us to understand how tumour cell (a) dissociation (b) invasion or (c) progression are controlled and how this is linked to the development of invasive or metastatic cancer.
We also explore properties of the three-dimensional tumour microenvironment that contribute to poor drug targeting in order to pinpoint critical barriers that impair efficient tumour targeting. Combination therapy aimed at counteracting these barriers are then employed to enhance drug penetrance and efficiency in vivo and improve overall drug delivery outcome.
A key to our laboratory’s approach is to use established in vitro and in vivo 2D and 3D technology to examine cancer progression at a sub-cellular and molecular level in situ. Key techniques and current applications include:
- Fluorescence Lifetime Imaging (FLIM) & Fluorescence Resonance Energy transfer (FRET) analysis allow for accurate, time-dependent, monitoring of signalling events during drug treatment in a live tumour setting.
- We use Fluorescence Recovery After Photobleaching (FRAP) & Photoactivation in live tumours to examine and predict cell-cell junction turnover during early stages of cancer dissemination and invasion.
3D organotypic matrices serve as a malleable platform for the assessment of vital tumour/stromal interaction in a 3D context, providing a powerful tool to complement in vivo investigations.
Please join us at the 8th Garvan Signalling Symposium, from October 31st to November 1st at The Garvan Institute of Medical Research.
Lab Awards and Honours
Sean Warren - Best Post Doc Presentation Prize at 7th International Nanomedicine Conference (29th June 2016)
Claire Vennin - Sydney Catalyst Research Scholarship and Top Up Awards (2016)
David Hermann - Young Garvan Award Finalist 2016: “Edgy Ideas”
Claire Vennin - 2015 Dennis Loather Student Poster Award at the Matrix Biology Society of Australia and New Zealand (30th October 2015)
Claire Vennin - Award for Best Presentation at the 23rd St Vincent's Campus Research Symposium (9th September 2015)
James Conway - Best poster at The Australian Society for Medical Research NSW Scientific Meeting 2015 (1st June 2015)
Claire Vennin - Best oral presentation award at the Sydney Catalyst Post-graduate and Early Career Symposium (29th April 2015)
Open source tools developed by the Timspon lab are available to download at http://github.com/timpsonlab.
3D Organotypic Matrix Database/Resource
Our 3D Organotypic Matrix Database/Resource contains over 4,000 organotypic invasion samples and embedded tissues.
In the News
A “biosensor mouse” that can predict the spread of pancreatic cancer - Jan 06, 2016
NHMRC funding success for Garvan researchers - Nov 09, 2015
A versatile mouse that can teach us about many diseases and drugs - Mar 14, 2014
Nanotechnology helps track and improve drug action in pancreatic cancer - Jun 12, 2013
Luxi Zhang wins 2012 Castle Harlan Award - Nov 06, 2012
Garvan performs well in NHMRC grants round - Oct 24, 2012